Alessandro Bonzano

Candiolo, 10060, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT).

Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT).

Journal: Oncology reports
Published: July 21, 2022

Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing.

Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing.

Journal: ESC heart failure
Published: January 14, 2021

The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3.

The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3.

Journal: International journal of molecular sciences
Published: June 30, 2020

Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study.

Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study.

Journal: Cancers
Published: November 06, 2019

ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy.

ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy.

Journal: International journal of molecular sciences
Published: March 22, 2019

Safe Use of Carfilzomib in a Patient with Multiple Myeloma and Intermittent Type 1 Brugada ECG Pattern: A Case Report.

Safe Use of Carfilzomib in a Patient with Multiple Myeloma and Intermittent Type 1 Brugada ECG Pattern: A Case Report.

Journal: Acta haematologica
Published: January 26, 2019

Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro.

Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro.

Journal: British journal of pharmacology
Published: September 07, 2018

Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidity.

Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidity.

Journal: The breast journal
Published: March 04, 2018

Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: a prospective evaluation.

Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: a prospective evaluation.

Journal: Future oncology (London, England)
Published: January 11, 2018

Fluoropyrimidine-induced cardiotoxicity.

Fluoropyrimidine-induced cardiotoxicity.

Journal: Critical reviews in oncology/hematology
Published: June 08, 2017
Showing 1-10 of 10

Last Updated: 09/26/2026